Moody's: HealthTronics unchanged

Moody's Investors Service said it said that HealthTronics, Inc.'s proposed acquisition of Endocare, announced on June 8, does not have any immediate impact to HealthTronics' ratings.

The agency said that the increase in financial leverage as a result of the acquisition is within its expectations and is already reflected in the B2 corporate family rating.

The last rating action was Oct. 21, when Moody's said it downgraded HealthTronics corporate family rating to B2 from B1 and changed to the outlook to stable from negative.

According to the agency, HealthTronics' ratings were assigned by evaluating factors we believe are relevant to the credit profile of the issuer, such as i) the business risk and competitive position of the company versus others within its industry, ii) the capital structure and financial risk of the company, iii) the projected performance of the company over the near to intermediate term, and iv) management's track record of tolerance for risk.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.